Literature DB >> 1665275

The reverse transforming effects of nerve growth factor on five human neurogenic tumor cell lines: in vitro results.

M J Yaeger1, A Koestner, K Marushige, Y Marushige.   

Abstract

The role of nerve growth factor (NGF) in the development, maintenance and regeneration of the mammalian sensory and sympathetic nervous systems has been well characterized, as has the ability of NGF to induce a variety of neoplastic cell lines of neuroecto-dermal (neurogenic) origin to differentiate. The ability to stimulate neoplastic cells of neurogenic origin to differentiate suggests that NGF may prove useful as a reverse transforming agent for the treatment of neurogenic tumors. Five human neurogenic tumor cell lines were evaluated for their response to NGF in vitro to determine whether the NGF is capable of inducing changes consistent with a reverse transforming response. Results indicate that NGF was able to reverse some of the transformed properties of these tumor cell lines, as NGF treatment stimulated neoplastic cells to develop a more differentiated phenotype, diminished or arrested growth, and induced changes that were persistent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665275     DOI: 10.1007/bf00294433

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  44 in total

1.  Alteration of cellular adhesion by nerve growth factor.

Authors:  D Schubert; C Whitlock
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

2.  Relationship among types of nerve growth factor receptors on PC12 cells.

Authors:  S Buxser; D Decker; P Ruppel
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

3.  Assaying binding of nerve growth factor to cell surface receptors.

Authors:  R D Vale; E M Shooter
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

4.  Induction of neurite outgrowth in the IMR-32 human neuroblastoma cell line by nerve growth factor.

Authors:  C P Reynolds; J R Perez-Polo
Journal:  J Neurosci Res       Date:  1981       Impact factor: 4.164

5.  A single Mr approximately 103,000 125I-beta-nerve growth factor-affinity-labeled species represents both the low and high affinity forms of the nerve growth factor receptor.

Authors:  S H Green; L A Greene
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

6.  Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.

Authors:  A H Ross; P Grob; M Bothwell; D E Elder; C S Ernst; N Marano; B F Ghrist; C C Slemp; M Herlyn; B Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

7.  Regulation of melanoma by the embryonic skin.

Authors:  M Gerschenson; K Graves; S D Carson; R S Wells; G B Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  The neurula stage mouse embryo in control of neuroblastoma.

Authors:  A H Podesta; J Mullins; G B Pierce; R S Wells
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  The effect of nerve growth factor on the development of sodium channels in PC12 cells.

Authors:  J K Reed; D England
Journal:  Biochem Cell Biol       Date:  1986-11       Impact factor: 3.626

10.  Characterization of functional nerve growth factor-receptors in a CNS glial cell line: monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells.

Authors:  S Kumar; J Huber; L A Peña; J R Perez-Polo; K Werrbach-Perez; J de Vellis
Journal:  J Neurosci Res       Date:  1990-11       Impact factor: 4.164

View more
  6 in total

1.  Soluble factors, including TNF alpha, secreted by human T cells are both cytotoxic and cytostatic for medulloblastoma cells.

Authors:  N Dufay; A Reboul; F Touraine-Moulin; M F Belin; P Giraudon
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

2.  Symmetrical neurofibroma with Schwann cell predominance and focal formation of microneurinomas.

Authors:  R Schober; G Reifenberger; G Kremer; H Urich
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 3.  Mitogens as motogens.

Authors:  M R Chicoine; D L Silbergeld
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

4.  Nerve growth factor plays a divergent role in mediating growth of rat C6 glioma cells via binding to the p75 neurotrophin receptor.

Authors:  Carla Weis; Bettina Wiesenhofer; Christian Humpel
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

5.  The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results.

Authors:  M J Yaeger; A Koestner; K Marushige; Y Marushige
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  The expression and localisation of beta-nerve growth factor (beta-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation.

Authors:  A B Paul; E S Grant; F K Habib
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.